InMode (INMD) vs Pacific Biosciences of California (PACB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pacific Biosciences of California (PACB) has outperformed InMode (INMD) over the past year, gaining 94.3% versus a loss of 6.8%. Over five years, INMD leads with a -83.2% price change compared with -88.8% for PACB. InMode is the larger company by market cap ($810.2 million vs $714.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INMD | PACB |
|---|---|---|
| Share price | $14.08 | $2.30 |
| Market cap | $810.22M | $714.91M |
| 1-day change | +0.50% | -15.44% |
| YTD return | -4.63% | +45.45% |
| 1-year return | -6.79% | +94.29% |
| 5-year return | -83.20% | -88.85% |
| P/E ratio (TTM) | 11.64 | — |
| Forward P/E | 10.26 | — |
| EPS (TTM) | $1.21 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.74 | $3.44 |
| 52-week low | $12.72 | $1.07 |
| Distance from 52-week high | -15.89% | -33.14% |
| Analyst consensus | none | buy |
| Avg. price target upside | +14.84% | -6.09% |
| Average volume | 521.98K | 10.10M |
| Shares outstanding | 57.54M | 310.83M |
| Employees | 660 | 485 |
| Sector | Health Care | Industrials |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PACB has outperformed INMD by 101.1 percentage points over the past year.
- The two companies sit in different sectors: InMode in Health Care and Pacific Biosciences of California in Industrials.
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 660 employees
About Pacific Biosciences of California
PACB stock →Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 485 employees
INMD vs PACB FAQ
Which is bigger, InMode or Pacific Biosciences of California?
InMode (INMD) is larger, with a market capitalization of $810.22M compared with $714.91M for Pacific Biosciences of California (PACB).
Which stock has performed better over the past year, INMD or PACB?
PACB returned +94.29% over the past 12 months, compared with -6.79% for INMD (price return, excluding dividends). Past performance does not predict future results.
Are InMode and Pacific Biosciences of California in the same industry?
No. InMode is in the Health Care sector, while Pacific Biosciences of California is in Industrials.